Nov 7, 2022: Digital healthcare news  

In this fast-paced world, Hidoc Dr newsletters are a great way to keep an eye on the latest pharmaceutical and digital marketing trends that can be applied to your digital marketing strategy. Today we deliver to you a variety of upcoming news and ideas related to drug clinical trials, technology advancements in novel formulation, particle engineering, and pharma digital marketing.

Clinical Trial Updates – Global 

  • Torsemide vs. Furosemide Trial finds no benefit in Heart Failure (PT)

Best Practices in Digital Marketing 

  • Under the proposed FTA, India aims for greater market access for pharmaceutical products in the United Kingdom: Official (OI)
  • AstraZeneca hands omnichannel ops mandate to Indegene (MMM)

Technology Advances – Global

  • Putting a Spotlight on Particle Engineering (PT)
  • Novel Formulations and Line Extensions Using Soft Capsule Technology (PT)

Physician Updates

  • Discovering the ideal role for Omecamtiv Mecarbil in HFrEF, with Nihar Desai, MD, MPH (PC)

About Hidoc Dr:
Our company Hidoc Dr. is a Digital Platform for Doctors with an audited reach of 8 Lakh Doctors across India. Hidoc Dr. provides Digital Marketing services to your brands to reach Doctors across all Specializations and GeographiesHidoc Digital Solutions guarantee 3x Brand Recall compared to any other digital solutions today.

Be the first to comment

Leave a Reply

Your email address will not be published.


*